Impact BioMedical Inc. (IBO) Company Profile & Statistics

Impact BioMedical Inc.
IBO
(AMEX)
Closed
2.59
-0.03 (-1.15%)
in:usd•As of: Nov 22, 2024 10:52 UTC -5
Pre Market:0+0.00 (0.00%)
Open
2.59
High
2.59
Low
2.59

About Impact BioMedical Inc.

CEO

Frank D. Heuszel

Headquarters

1400 broadfield blvd., suite 130

houston, tx 77084, united states

Auditor

GRASSI & CO.

Employees

Share Holders

393

Website

www.impactbiomedinc.com

Industry

electronic equipment or instruments

Sector

electronic technology

Company Overview

Impact BioMedical Inc. discovers, confirms and patents unique science and technologies resulting in new offerings in human healthcare and wellness. Impact BioMedical Inc. is based in NEW YORK.

Impact BioMedical Inc. Statistics

Valuation Measures

Market Capitalization ²	29.79M
Enterprise Value	35.12M
Enterprise Value/EBITDA (ttm)	-13.81
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.88
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-15.74%
Return on Invested Capital (ttm)	-1.45%
Return on Assets (ttm)	-10.16%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-2.54M
Net Income Avi to Common (ttm)	981.00K
Diluted EPS (ttm)	N/A

Share Statistics

Beta (5Y Monthly)	N/A
52-Week Change	N/A
S&P500 52-Week Change	31.18%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	11.50M
Dividend Yield	0.00%
Float ⁴	0.00
% Held by Insiders	N/A
% Held by Institutions	N/A

Balance Sheet

Total Cash (mrq)	2.67M
Total Cash Per Share (mrq)	0.23
Total Debt (mrq)	8.01M
Total Debt/Equity (mrq)	23.31%
Current Ratio (mrq)	2.79%
Quick Ratio (mrq)	2.79%
Book Value Per Share (mrq)	2.99

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.04
Free Cash Flow (ytd)	-2.66M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Impact BioMedical Inc.

Trade With A Regulated Broker